Propel Bio Management’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-56,359
Closed -$2.27M 23
2024
Q4
$2.27M Hold
56,359
2.25% 12
2024
Q3
$2.67M Hold
56,359
1.55% 12
2024
Q2
$1.68M Hold
56,359
1.09% 18
2024
Q1
$2.27M Hold
56,359
1.32% 15
2023
Q4
$1.43M Buy
+56,359
New +$1.43M 1.19% 22